Atlas Trials

Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers

Clinical trial NCT00656825 · COMPLETED

Trial details

NCT number
NCT00656825
Sponsor
ISDIN
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2007-03-01
Primary completion
2007-06-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.